Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.345 USD | +5.16% | +4.34% | +66.79% |
28/05 | Chardan Research Starts iBio With Buy Rating, $5 Price Target | MT |
13/05 | IBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+66.79% | 19.23M | |
+39.23% | 734B | |
+32.83% | 591B | |
-6.42% | 350B | |
+14.77% | 315B | |
+2.27% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+5.37% | 161B |
- Stock Market
- Equities
- IBIO Stock
- News iBio, Inc.
- Transcript : iBio, Inc. - Shareholder/Analyst Call